📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats. (2020)

First Author: Onwordi EC

Attributed to: Analysis of Mitochondrial Imaging Biomarkers in Neurodegenerative Disease funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-019-14122-0

PubMed Identifier: 31937764

Publication URI: http://europepmc.org/abstract/MED/31937764

Type: Journal Article/Review

Volume: 11

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723